Literature DB >> 20394501

The role of matrix metalloproteinase 2 on the survival of patients with non-small cell lung cancer: a systematic review with meta-analysis.

Qian Qian1, Qian Wang, Ping Zhan, Ling Peng, Shu-Zhen Wei, Yi Shi, Yong Song.   

Abstract

To evaluate the prognostic value of matrix metalloproteinase2 (MMP-2) expression in patients with non-small cell lung cancer (NSCLC), the electronic database PubMed, EMBASE were searched for relevant articles. The meta-analysis was finally based on 11 studies that included 1,439 patients, and combined HR was 1.66 (95% confidence intervals (CI: 1.37-2.01). Its effect also appeared significant when the analysis was restricted to tumor cell expression and patients with adenocarcinoma (HR 2.08 (95% CI: 1.24-3.48)). This study supported the fact that MMP-2 could be included in further prospective trials studying prognostic factors in NSCLC.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20394501     DOI： 10.3109/07357901003735634

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


  39 in total

1.  PD-L1 over-expression and survival in patients with non-small cell lung cancer: a meta-analysis.

Authors:  Ze-Jun Zhou; Ping Zhan; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2015-04

2.  VEGF +936C/T and +460C/T gene polymorphisms and oral cancer risk: a meta-analysis.

Authors:  Su-Feng Zhao; Ping Zhan; Xu-Dong Yang; Ming-Xing Lu; Guo-Wen Sun; Yu-Xin Wang; Yin-Kai Zhang; Yu-Mei Pu; En-Yi Tang
Journal:  Mol Biol Rep       Date:  2013-09-22       Impact factor: 2.316

Review 3.  Prognostic value of survivin expression in breast cancer patients: a meta-analysis.

Authors:  Jian Song; Hong Su; Yang-Yang Zhou; Liang-Liang Guo
Journal:  Tumour Biol       Date:  2013-05-21

4.  Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2.

Authors:  Jie Gu; Feng-kai Xu; Guang-yin Zhao; Chun-lai Lu; Zong-wu Lin; Jian-yong Ding; Di Ge
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

5.  Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.

Authors:  Yonggang Liang; Shanxian Guo; Qinghua Zhou
Journal:  Tumour Biol       Date:  2013-12-14

6.  The role of SOX-2 on the survival of patients with non-small cell lung cancer.

Authors:  Wenlong Shao; Hanzhang Chen; Jianxing He
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

7.  Anti-metastatic effects of isolinderalactone via the inhibition of MMP-2 and up regulation of NM23-H1 expression in human lung cancer A549 cells.

Authors:  Cheng-Hung Chuang; Li-Yu Wang; Yuen Man Wong; En-Shyh Lin
Journal:  Oncol Lett       Date:  2018-01-25       Impact factor: 2.967

8.  Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Ping Zhan; Qian Qian; Li-Ke Yu
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

Review 9.  Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets.

Authors:  Elin Hadler-Olsen; Jan-Olof Winberg; Lars Uhlin-Hansen
Journal:  Tumour Biol       Date:  2013-05-17

10.  Migration and epithelial-to-mesenchymal transition of lung cancer can be targeted via translation initiation factors eIF4E and eIF4GI.

Authors:  Oshrat Attar-Schneider; Liat Drucker; Maya Gottfried
Journal:  Lab Invest       Date:  2016-08-08       Impact factor: 5.662
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.